Lowdose Nivolumab in Combination With AVD as Front Line Therapy for Classic Hodgkin's Lymphoma
Clinical trial NCT05772624 · UNKNOWN
Trial details
- NCT number
- NCT05772624
- Sponsor
- Hospital Universitario Dr. Jose E. Gonzalez
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-02-13
- Primary completion
- 2024-03-01
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.